ArticleMethods in molecular biology (Clifton, N.J.)2026
Epitope Binning: Clustering Monoclonal Antibodies on Monomeric and Multivalent Antigens.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of antibodies for either detection or therapeutics requires extensive characterization of several potential leads. One of the critical steps in the characterization process is epitope mapping (binning), where the different antibodies are divided into "bins" according to their antigen recognition site, which is directly linked to their functional activity. Biolayer interferometry (BLI) is a technology used to characterize interactions between macromolecules and, as such, is used extensively to characterize antibodies. The current protocol describes the use of BLI for antibody binning. Along the classical pairwise mapping model, this protocol addresses the challenges of binning on multivalent antigens as well as characterizing non-purified antibodies.
Indexed as
Identifiers
42129094What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.